Nicotine patch therapy prior to quitting smoking: a meta‐analysis
Abstract
Aim To evaluate the incremental efficacy of starting nicotine patch treatment prior to quitting compared to the current regimen of starting patch treatment on the target quit day. Design and measurements Meta‐analysis of four eligible studies using pre‐cessation patch treatment, located by database search and contacts with cessation researchers. The studies all compared starting treatment with nicotine patch prior to the target quit date to starting active treatment at the quit date, some in the context of concurrent mecamylamine treatment. The primary end‐point for the analysis was continuous abstinence for at least 28 days assessed at 6 weeks following quit day; 6‐month outcomes were also examined. Findings Compared to starting active patch treatment on quit day, pre‐cessation treatment with nicotine patches was found to double the odds of quitting. This was true both at 6 weeks [pooled odds ratio (OR) = 1.96, 95% confidence interval (CI): 1.31–2.93] and 6 months (pooled OR = 2.17, 95% CI: 1.46–3.22) treatment outcomes. Mecamylamine co‐treatment did not modify these effects. Conclusions Across the four studies analyzed, pre‐cessation patch treatment was found to produce a robust increase in quit rates compared to current regimens starting patch at quit day. Pre‐cessation patch use represents a promising innovation in smoking cessation therapy with potential beneficial implications for improved public health by further increasing quitting success.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Using nicotine patches for 2 weeks prior to the quit date appears to improve long-term abstinence rates.
“This would explain why using nicotine patches for 2 weeks prior to the quit date appears to improve long-term abstinence rates (34);”
From The Multiple Facets of Cigarette Addiction and What They Mean for Encouraging and Helping Smokers to Stop (2009) · cites this paper as [34]
Cites
Treating tobacco use and dependence-Clinical practice guideline
Mc, F. (2000) · Medical Entomology and Zoology · Cited by 3,616 · see citing works
Jorenby, D. E. (2006) · JAMA · doi:10.1001/jama.296.1.56 · Cited by 1,635 · see citing works
Nicotine and nonnicotine factors in cigarette addiction
Rose, J. E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0250-x · Cited by 348 · see citing works
Under-use of smoking-cessation treatments
Cokkinides, V. E., Ward, E., Jemal, A., & Thun, M. J. (2004) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2004.09.007 · Cited by 260 · see citing works
Staley, J. K., Krishnan-Sarin, S., Cosgrove, K. P., Krantzler, E., Frohlich, E., Perry, E., Dubin, J. A., Estok, K., Brenner, E., Baldwin, R. M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0546-06.2006 · Cited by 223 · cited 1× · see citing works
“While the terminal half-life of nicotine is ~ 2 hours [14], a recent imaging study [15] suggests that nicotine may reside on the nicotine receptor for a longer duration.”
Wennike, P., Danielsson, T., Landfeldt, B., Westin, Å., & Tønnesen, P. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00489.x · Cited by 163 · see citing works
Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.
Rose, J. E., Behm, F. M., & Westman, E. C. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037//1064-1297.6.3.331 · Cited by 159 · see citing works
Nicotine–mecamylamine treatment for smoking cessation: The role of pre-cessation therapy.
Rose, J. E., Behm, F. M., & Westman, E. C. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.6.3.331 · Cited by 146 · see citing works
Shiffman, S., Ferguson, S. G., & Gwaltney, C. J. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0175-4 · Cited by 114 · see citing works
Self-citationEffect of transdermal nicotine patches on cigarette smoking: a double blind crossover study
Foulds, J., Stapleton, J., Feyerabend, C., VESEY, C. J., Jarvis, M. J., & Russell, M. A. (1992) · Psychopharmacology · doi:10.1007/bf02245429 · Cited by 112 · see citing works
Precessation treatment with nicotine skin patch facilitates smoking cessation
Rose, J. E., Behm, F. M., Westman, E. C., & Kukovich, P. (2006) · Nicotine & Tobacco Research · doi:10.1080/14622200500431866 · Cited by 111 · see citing works
Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine
Benowitz, N. L., Zevin, S., & Jacob, P. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37887-5 · Cited by 108 · see citing works
Nicotine concentrations with concurrent use of cigarettes and nicotine replacement: A review
Fagerström, K. O., & Hughes, J. R. (2002) · Nicotine & Tobacco Research · doi:10.1080/1462220021000032753 · Cited by 102 · see citing works
Nicotine Gum, 2 and 4 mg, for Nicotine Dependence
Herrera, N., Franco, R., Herrera, L., Partidas, A., Rolando, R., & Fagerström, K. O. (1995) · Chest · doi:10.1378/chest.108.2.447 · Cited by 101 · see citing works
Reducing Tobacco Use: A Report of the Surgeon General: Executive Summary
(2000) · PsycEXTRA Dataset · doi:10.1037/e300842003-001 · Cited by 93 · see citing works
Fant, R. V., Henningfield, J. E., Shiffman, S. S., Strahs, K. R., & Reitberg, D. P. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00399-3 · Cited by 84 · see citing works
Self-citationSchuurmans, M. M., Diacon, A. H., van Biljon, X., & Bolliger, C. T. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00711.x · Cited by 81 · see citing works
Smokers' interest in using nicotine replacement to aid smoking reduction
Shiffman, S. M., Hughes, J. R., Ferguson, S. G., Pillitteri, J. L., Gitchell, J. G., & Burton, S. L. (2007) · Nicotine & Tobacco Research · doi:10.1080/14622200701648441 · Cited by 64 · see citing works
Self-citationReducing Tobacco Use: A Report of the Surgeon General - Executive Summary
(2000) · Nicotine & Tobacco Research · doi:10.1080/713688157 · Cited by 46 · see citing works
Effects of nicotine chewing gum on cigarette smoking and subjective and physiologic effects
Nemeth-Coslett, R., & Henningfield, J. E. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.110 · Cited by 42 · see citing works
Glover, E. D., Laflin, M. T., Schuh, K. J., Schuh, L. M., Nides, M., Christen, A. G., Glover, P. N., & Strnad, J. V. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01763.x · Cited by 38 · see citing works
Nicotine Pharmacology and Addiction
Benowitz, N. (1998) · doi:10.1093/oso/9780195114966.003.0001 · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Liu, J., Davidson, E., Bhopal, R., White, M., Johnson, M., Netto, G., Deverill, M., & Sheikh, A. (2012) · Health Technology Assessment · doi:10.3310/hta16440 · Cited by 237 · see citing works
West, R. (2009) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550903049181 · Cited by 145 · see citing works
Treatment of nicotine addiction: present therapeutic options and pipeline developments
Polosa, R., & Benowitz, N. L. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.12.008 · Cited by 135 · see citing works
Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice
Aubin, H., Luquiens, A., & Berlin, I. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12116 · Cited by 138 · see citing works
Chang, P.-H., Chiang, C.-H., Ho, W.-C., Wu, P.-Z., Tsai, J.-S., & Guo, F.-R. (2015) · BMC Public Health · doi:10.1186/s12889-015-2055-0 · Cited by 108 · see citing works
Pharmacotherapy for smoking cessation: present and future
Aubin, H.-J., Karila, L., & Reynaud, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796150837 · Cited by 39 · see citing works
- Authors
- Shiffman, S., & Ferguson, S. G.
- Affiliations
- Pinney Associates (United States) (US)
- University of Pittsburgh (US)
- Corresponding author
- Shiffman, Saul
- ORCID
- Ferguson, Stuart G.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2008-03-13
- Volume
- 103
- Issue
- 4
- Pages
- 557-563
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W2141007290
- Semantic Scholar
- 79075c4008a5942bdcb796f08f1fde182dd892e9
- Cited by
- 94
- References
- 22
- Citations by year
- 2023: 2 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 8 · 2017: 4 · 2016: 5 · 2015: 8 · 2014: 6 · 2013: 9 · 2012: 9
- FWCI
- 7.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Addiction (publishedVersion)
- PubMed (publishedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- Funders
- GlaxoSmithKline
- Topics
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
- Keywords
- nicotine patch, smoking cessation, nicotine replacement therapy, mecamylamine, quit rates, continuous abstinence, treatment timing
- MeSH terms
- Administration, Cutaneous, Humans, Nicotine, Substance Withdrawal Syndrome, Randomized Controlled Trials as Topic, Smoking Cessation, Nicotinic Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
